Is Cosentyx (secukinumab) an anti-inflammatory?
Yes. Cosentyx is an anti-inflammatory medicine. It works by targeting interleukin-17A (IL‑17A), a signaling protein involved in inflammatory processes. By blocking IL‑17A, Cosentyx helps reduce inflammation in diseases such as plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis [1].
What inflammation-related conditions does Cosentyx treat?
Cosentyx is used for immune-mediated, inflammation-driven conditions including:
- Plaque psoriasis
- Psoriatic arthritis
- Ankylosing spondylitis
- Non-radiographic axial spondyloarthritis
- Certain forms of juvenile idiopathic arthritis (as approved/indicated in prescribing information) [1]
How fast does it usually work for inflammation?
The degree and timing of improvement varies by condition and person. Prescribing information and clinical study results describe improvements in symptoms and inflammation-related outcomes over weeks, with benefits often seen within the first several weeks of treatment [1].
Is it the same as a steroid anti-inflammatory?
No. Cosentyx is a biologic that specifically blocks IL‑17A, rather than a corticosteroid. Steroids broadly reduce inflammation, while Cosentyx targets a particular inflammatory pathway [1].
Sources
[1] https://www.cosentyx.com/